Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease
- 1 July 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 22 (7) , 1596-1608
Abstract
Background. Distinct CD8+ T-cell subsets such as interleukin-17-expressing Tc17 and Foxp3-expressing Tcreg are functionally similar to CD4+ T cells. Though CD4Keywords
This publication has 64 references indexed in Scilit:
- Increased Frequency of CD4 and CD8 Regulatory T Cells in Individuals under 15 Years with Multibacillary LeprosyPLOS ONE, 2013
- Whole Genome Gene Expression Meta-Analysis of Inflammatory Bowel Disease Colon Mucosa Demonstrates Lack of Major Differences between Crohn's Disease and Ulcerative ColitisPLOS ONE, 2013
- Availability of 25-Hydroxyvitamin D3 to APCs Controls the Balance between Regulatory and Inflammatory T Cell ResponsesThe Journal of Immunology, 2012
- Functionally Suppressive CD8 T Regulatory Cells Are Increased in Patients with Multiple Myeloma: A Cause for Immune ImpairmentPLOS ONE, 2012
- The role of 1α,25‐dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+and IL‐10+CD4+T cellsEuropean Journal of Immunology, 2012
- Osteoclast Activated FoxP3+ CD8+ T-Cells Suppress Bone Resorption in vitroPLOS ONE, 2012
- Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel diseaseJournal of Translational Medicine, 2011
- Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitisJournal of Clinical Investigation, 2011
- 1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cellsImmunology Letters, 2010
- Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancerTherapeutic Advances in Gastroenterology, 2010